Cargando…

ROC1 promotes the malignant progression of bladder cancer by regulating p-IκBα/NF-κB signaling

BACKGROUND: Regulator of cullins 1 (ROC1) is an important catalytic subunit of cullin–RING E3 ligase. Nuclear factor-kappa B (NF-κB) signaling is closely related to tumor invasion and metastasis. Earlier, we reported that ROC1 was associated with a poor prognosis in patients with bladder cancer (BCa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Qi, Zhou, Xiaoqing, Li, Peng, Ding, Mao, You, Shengjie, Xu, Zhaoyu, Ye, Junjie, Chen, Xuedong, Tan, Mingyue, Wang, Jun, Wang, Wei, Qiu, Jianxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106150/ https://www.ncbi.nlm.nih.gov/pubmed/33962660 http://dx.doi.org/10.1186/s13046-021-01935-5

Ejemplares similares

SAG/ROC2 E3 ligase regulates skin carcinogenesis by stage-dependent targeting of c-Jun/AP1 and IκB-α/NF-κB
por: Gu, Qingyang, et al.
Publicado: (2007)

NF-κB in Hematological Malignancies
por: Imbert, Véronique, et al.
Publicado: (2017)

DDRGK1 Regulates NF-κB Activity by Modulating IκBα Stability
por: Xi, Peng, et al.
Publicado: (2013)

Role of Monoubiquitylation on the Control of IκBα Degradation and NF-κB Activity
por: Da Silva-Ferrada, Elisa, et al.
Publicado: (2011)

Beyond NF-κB activation: nuclear functions of IκB kinase α
por: Huang, Wei-Chien, et al.
Publicado: (2013)

Suppression of NF-κB and NF-κB-Regulated Gene Expression by Apigenin through IκBα and IKK Pathway in TRAMP Mice
por: Shukla, Sanjeev, et al.
Publicado: (2015)

Polymorphisms of NFκB1 and IκBα and Their Synergistic Effect on Nasopharyngeal Carcinoma Susceptibility
por: Liu, Yehua, et al.
Publicado: (2015)

Single TNFα trimers mediating NF-κB activation: stochastic robustness of NF-κB signaling
por: Lipniacki, Tomasz, et al.
Publicado: (2007)

Histone deacetylase 4 inhibits NF-κB activation by facilitating IκBα sumoylation
por: Yang, Qi, et al.
Publicado: (2021)

TRIM22 activates NF-κB signaling in glioblastoma by accelerating the degradation of IκBα
por: Ji, Jianxiong, et al.
Publicado: (2020)

Expression of COX-2, NF-κB-p65, NF-κB-p50 and IKKα in malignant and adjacent normal human colorectal tissue
por: Charalambous, M P, et al.
Publicado: (2009)

NF-κB-Dependent and -Independent (Moonlighting) IκBα Functions in Differentiation and Cancer
por: Espinosa, Lluís, et al.
Publicado: (2021)

IκBα beyond the NF-kB dogma
por: Mulero, Maria Carmen, et al.
Publicado: (2013)

Nuclear Factor κB (NF-κB)–Mediated Inflammation in Multiple Sclerosis
por: Zhou, Yifan, et al.
Publicado: (2020)

NF-κB Mediates Tumor Necrosis Factor α-Induced Expression of Optineurin, a Negative Regulator of NF-κB
por: Sudhakar, Cherukuri, et al.
Publicado: (2009)

NF-κB and Disease
por: Poma, Paola
Publicado: (2020)

NF-κB and the Immunoglobulin κ Gene Enhancer
por: Sen, Ranjan
Publicado: (2004)

Mechanism of Probiotic VSL#3 Inhibiting NF-κB and TNF-α on Colitis through TLR4-NF-κB Signal Pathway
por: WANG, Hui, et al.
Publicado: (2019)

NF-κB Members Left Home: NF-κB-Independent Roles in Cancer
por: Colomer, Carlota, et al.
Publicado: (2017)

Molecular stripping, targets and decoys as modulators of oscillations in the NF-κB/IκBα/DNA genetic network
por: Wang, Zhipeng, et al.
Publicado: (2016)

The Role of NF-κB in PPARα-Mediated Hepatocarcinogenesis
por: Glauert, Howard P., et al.
Publicado: (2008)

Regulation of NF-κB by PML and PML-RARα
por: Ahmed, Abrar, et al.
Publicado: (2017)

The levels of NF-κB p50 and NF-κB p65 play a role in thyroid carcinoma malignancy in vivo
por: Le, Fei, et al.
Publicado: (2018)

Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets
por: Paul, Andrew, et al.
Publicado: (2018)

HAF drives the switch of HIF-1α to HIF-2α by activating the NF-κB pathway, leading to malignant behavior of T24 bladder cancer cells
por: GUAN, ZHENFENG, et al.
Publicado: (2013)

Epstein–Barr virus envelope glycoprotein 110 inhibits NF-κB activation by interacting with NF-κB subunit p65
por: Cai, Mingsheng, et al.
Publicado: (2023)

Regulation of IκBα expression involves both NF-κB and the MAP kinase signaling pathways
por: Zhang, Ning, et al.
Publicado: (2005)

Regulation of NF-κB inhibitor IκBα and viral replication by a KSHV microRNA
por: Lei, Xiufen, et al.
Publicado: (2010)

Suppression of NF-κB activity by mutant IκBα: A molecular target for radiosensitization of adenoid cystic carcinoma
por: LIU, ZHE, et al.
Publicado: (2013)

Berbamine Suppresses the Progression of Bladder Cancer by Modulating the ROS/NF-κB Axis
por: Han, Chenglin, et al.
Publicado: (2021)

Analysis of variation in NF-κB genes and expression levels of NF-κB-regulated molecules
por: Liu-Mares, Wen, et al.
Publicado: (2007)

miR-130b, an onco-miRNA in bladder cancer, is directly regulated by NF-κB and sustains NF-κB activation by decreasing Cylindromatosis expression
por: Cui, Xiaolu, et al.
Publicado: (2016)

Aberrant Activation of NF-κB Signalling in Aggressive Lymphoid Malignancies
por: Kennedy, Ruth, et al.
Publicado: (2018)

NF-κB fingerprinting reveals heterogeneous NF-κB composition in diffuse large B-cell lymphoma
por: Jayawant, Eleanor, et al.
Publicado: (2023)

Essential Role of Nuclear Factor (NF)-κB–Inducing Kinase and Inhibitor of κb (Iκb) Kinase α in Nf-κb Activation through Lymphotoxin β Receptor, but Not through Tumor Necrosis Factor Receptor I
por: Matsushima, Akemi, et al.
Publicado: (2001)

Regulation of hypoxia-inducible factor-1α by NF-κB
por: van Uden, Patrick, et al.
Publicado: (2008)

Keeping NF-κB in check
por: Williams, Ruth
Publicado: (2006)

At the crossroads of SUMO and NF-κB
por: Kracklauer, Martin P, et al.
Publicado: (2003)

Slow but steady for NF-κB
por: Leslie, Mitch
Publicado: (2012)

NF-κB in premature aging
por: Osorio, Fernando G., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ovramvels16im1rccosv6buts3